NCT05866562Phase 2Recruiting
Dupilumab in the Treatment of Pediatric Alopecia Areata
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Recruiting
- Declared phase
- Phase 2
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Participants (registry)
- 76
- Start
- July 2024
- Primary completion
- March 2029 (planned)
- Study completion
- April 2029 (planned)
- Last registry update
- September 2026
- Countries
- United States
Conditions studied: Alopecia Areata
Interventions: Dupilumab, Dupixent, Placebo
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.